Onderneming Puma Biotechnology Inc Nyse
Aandelen
US74587V1070
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cancer Care Products
100,0
%
| 228 | 100,0 % | 236 | 100,0 % | +3,34% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 228 | 100,0 % | 236 | 100,0 % | +3,34% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15-09-10 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 05-11-18 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 01-03-13 |
Investor Relations Contact | - | - | |
Jeffrey Ludwig
PRN | Corporate Officer/Principal | 58 | 01-03-20 |
Douglas Hunt
LAW | General Counsel | 59 | 01-01-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 23-02-18 |
Jay Moyes
BRD | Director/Board Member | 70 | 27-04-12 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15-09-10 |
Director/Board Member | 63 | 29-07-22 | |
Director/Board Member | 60 | 11-08-15 | |
Troy Wilson
BRD | Director/Board Member | 55 | 18-10-13 |
Allison Dorval
BRD | Director/Board Member | 48 | 15-07-21 |
Brian Stuglik
BRD | Director/Board Member | 64 | 05-07-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 48 238 850 | 40 808 140 ( 84,60 %) | 0 | 84,60 % |
Bedrijfsgegevens
Puma Biotechnology, Inc.
10880 Wilshire Boulevard Suite 2150
90024-4101, Los Angeles
+
http://www.pumabiotechnology.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,86 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,66 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |